nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A5—Crohn's disease	0.597	1	CbGaD
Diphenhydramine—PTGS1—Balsalazide—Crohn's disease	0.149	0.413	CbGbCtD
Diphenhydramine—PTGS1—Mesalazine—Crohn's disease	0.119	0.33	CbGbCtD
Diphenhydramine—PTGS1—Sulfasalazine—Crohn's disease	0.0666	0.185	CbGbCtD
Diphenhydramine—CYP2C19—Prednisone—Crohn's disease	0.0258	0.0715	CbGbCtD
Diphenhydramine—Imipramine—SLC22A4—Crohn's disease	0.000206	0.186	CrCbGaD
Diphenhydramine—Oxaprozin—PTGS2—Crohn's disease	0.000178	0.16	CrCbGaD
Diphenhydramine—Fenoprofen—PTGS2—Crohn's disease	0.000147	0.133	CrCbGaD
Diphenhydramine—Fenoprofen—ALB—Crohn's disease	0.000131	0.118	CrCbGaD
Diphenhydramine—Phenylbutazone—PTGS2—Crohn's disease	0.000117	0.106	CrCbGaD
Diphenhydramine—Phenprocoumon—ALB—Crohn's disease	0.000113	0.102	CrCbGaD
Diphenhydramine—Warfarin—ALB—Crohn's disease	0.0001	0.0903	CrCbGaD
Diphenhydramine—HRH1—IL-4 Signaling Pathway—JAK2—Crohn's disease	8.71e-05	0.00227	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	8.54e-05	0.00223	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	8.51e-05	0.00222	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	8.48e-05	0.00221	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.36e-05	0.00218	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	8.35e-05	0.00218	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	7.96e-05	0.00208	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.8e-05	0.00203	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	7.68e-05	0.002	CbGpPWpGaD
Diphenhydramine—Photosensitivity—Mesalazine—Crohn's disease	7.53e-05	0.0299	CcSEcCtD
Diphenhydramine—CHRM2—G alpha (i) signalling events—CCR6—Crohn's disease	7.48e-05	0.00195	CbGpPWpGaD
Diphenhydramine—Phenytoin—ALB—Crohn's disease	7.27e-05	0.0656	CrCbGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.11e-05	0.00185	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	7.1e-05	0.00185	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	7.07e-05	0.00184	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	7.06e-05	0.00184	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	7e-05	0.00183	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.96e-05	0.00182	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.96e-05	0.00182	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CCR9—Crohn's disease	6.95e-05	0.00181	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	6.94e-05	0.00181	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.89e-05	0.0018	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CCR9—Crohn's disease	6.84e-05	0.00178	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—RASGRP1—Crohn's disease	6.62e-05	0.00173	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.49e-05	0.00169	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.49e-05	0.00169	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	6.48e-05	0.00169	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—GPR65—Crohn's disease	6.46e-05	0.00169	CbGpPWpGaD
Diphenhydramine—Neuritis—Prednisone—Crohn's disease	6.46e-05	0.0256	CcSEcCtD
Diphenhydramine—HRH1—IL-4 Signaling Pathway—STAT3—Crohn's disease	6.39e-05	0.00167	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—GPR65—Crohn's disease	6.36e-05	0.00166	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	6.21e-05	0.00162	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	6.21e-05	0.00162	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL10—Crohn's disease	6.12e-05	0.0016	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	6.11e-05	0.00159	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	6.04e-05	0.00158	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	5.99e-05	0.00156	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	5.95e-05	0.00155	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	5.92e-05	0.00154	CbGpPWpGaD
Diphenhydramine—Thrombocytopenia—Mercaptopurine—Crohn's disease	5.87e-05	0.0232	CcSEcCtD
Diphenhydramine—CYP2C18—Metabolism—PLA2G4F—Crohn's disease	5.78e-05	0.00151	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	5.78e-05	0.00151	CbGpPWpGaD
Diphenhydramine—Anorexia—Mercaptopurine—Crohn's disease	5.71e-05	0.0226	CcSEcCtD
Diphenhydramine—HRH1—GPCR downstream signaling—MLN—Crohn's disease	5.67e-05	0.00148	CbGpPWpGaD
Diphenhydramine—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	5.63e-05	0.00147	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—MLN—Crohn's disease	5.57e-05	0.00145	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.54e-05	0.00145	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ACKR2—Crohn's disease	5.43e-05	0.00142	CbGpPWpGaD
Diphenhydramine—Dysuria—Mesalazine—Crohn's disease	5.35e-05	0.0212	CcSEcCtD
Diphenhydramine—CHRM2—Signaling by GPCR—ACKR2—Crohn's disease	5.34e-05	0.00139	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	5.32e-05	0.00139	CbGpPWpGaD
Diphenhydramine—Pollakiuria—Mesalazine—Crohn's disease	5.28e-05	0.0209	CcSEcCtD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	5.24e-05	0.00137	CbGpPWpGaD
Diphenhydramine—Agranulocytosis—Azathioprine—Crohn's disease	5.22e-05	0.0207	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Mesalazine—Crohn's disease	5.22e-05	0.0207	CcSEcCtD
Diphenhydramine—Decreased appetite—Mercaptopurine—Crohn's disease	5.21e-05	0.0206	CcSEcCtD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.19e-05	0.00135	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MLN—Crohn's disease	5.14e-05	0.00134	CbGpPWpGaD
Diphenhydramine—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	5.13e-05	0.00134	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MLN—Crohn's disease	5.06e-05	0.00132	CbGpPWpGaD
Diphenhydramine—Neuropathy peripheral—Mesalazine—Crohn's disease	5e-05	0.0198	CcSEcCtD
Diphenhydramine—CYP2C18—Metabolism—MTMR3—Crohn's disease	4.91e-05	0.00128	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.91e-05	0.00128	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	4.89e-05	0.00128	CbGpPWpGaD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.88e-05	0.00127	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.82e-05	0.00126	CbGpPWpGaD
Diphenhydramine—Agranulocytosis—Mesalazine—Crohn's disease	4.76e-05	0.0189	CcSEcCtD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	4.69e-05	0.00122	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CCR6—Crohn's disease	4.6e-05	0.0012	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.57e-05	0.00119	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	4.53e-05	0.00118	CbGpPWpGaD
Diphenhydramine—Chills—Azathioprine—Crohn's disease	4.51e-05	0.0179	CcSEcCtD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.4e-05	0.00115	CbGpPWpGaD
Diphenhydramine—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.38e-05	0.00114	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	4.36e-05	0.00114	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.34e-05	0.00113	CbGpPWpGaD
Diphenhydramine—Amitriptyline—ALB—Crohn's disease	4.27e-05	0.0386	CrCbGaD
Diphenhydramine—Tinnitus—Mesalazine—Crohn's disease	4.27e-05	0.0169	CcSEcCtD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	4.19e-05	0.00109	CbGpPWpGaD
Diphenhydramine—Euphoric mood—Prednisone—Crohn's disease	4.14e-05	0.0164	CcSEcCtD
Diphenhydramine—Chills—Mesalazine—Crohn's disease	4.11e-05	0.0163	CcSEcCtD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.1e-05	0.00107	CbGpPWpGaD
Diphenhydramine—Diarrhoea—Mercaptopurine—Crohn's disease	4.1e-05	0.0162	CcSEcCtD
Diphenhydramine—HRH1—GPCR ligand binding—PTGER4—Crohn's disease	4.05e-05	0.00106	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.04e-05	0.00105	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	3.99e-05	0.00104	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CCR9—Crohn's disease	3.93e-05	0.00102	CbGpPWpGaD
Diphenhydramine—Tension—Mesalazine—Crohn's disease	3.91e-05	0.0155	CcSEcCtD
Diphenhydramine—Nervousness—Mesalazine—Crohn's disease	3.87e-05	0.0153	CcSEcCtD
Diphenhydramine—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	3.86e-05	0.00101	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	3.84e-05	0.001	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—FADS1—Crohn's disease	3.83e-05	0.000999	CbGpPWpGaD
Diphenhydramine—Vomiting—Mercaptopurine—Crohn's disease	3.81e-05	0.0151	CcSEcCtD
Diphenhydramine—Rash—Mercaptopurine—Crohn's disease	3.78e-05	0.015	CcSEcCtD
Diphenhydramine—Dermatitis—Mercaptopurine—Crohn's disease	3.77e-05	0.015	CcSEcCtD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.76e-05	0.00098	CbGpPWpGaD
Diphenhydramine—Vision blurred—Mesalazine—Crohn's disease	3.75e-05	0.0149	CcSEcCtD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.74e-05	0.000975	CbGpPWpGaD
Diphenhydramine—Tremor—Mesalazine—Crohn's disease	3.73e-05	0.0148	CcSEcCtD
Diphenhydramine—PTGS1—Metabolism—PLA2G4F—Crohn's disease	3.72e-05	0.000972	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—GPR65—Crohn's disease	3.65e-05	0.000952	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	3.59e-05	0.000937	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GPX4—Crohn's disease	3.59e-05	0.000935	CbGpPWpGaD
Diphenhydramine—Vertigo—Mesalazine—Crohn's disease	3.58e-05	0.0142	CcSEcCtD
Diphenhydramine—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	3.58e-05	0.000933	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCR9—Crohn's disease	3.57e-05	0.00093	CbGpPWpGaD
Diphenhydramine—Nausea—Mercaptopurine—Crohn's disease	3.56e-05	0.0141	CcSEcCtD
Diphenhydramine—Palpitations—Mesalazine—Crohn's disease	3.52e-05	0.014	CcSEcCtD
Diphenhydramine—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	3.51e-05	0.000915	CbGpPWpGaD
Diphenhydramine—Thrombocytopenia—Azathioprine—Crohn's disease	3.49e-05	0.0138	CcSEcCtD
Diphenhydramine—CYP2C18—Metabolism—GCKR—Crohn's disease	3.46e-05	0.000903	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	3.38e-05	0.000883	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.35e-05	0.000873	CbGpPWpGaD
Diphenhydramine—Irritability—Prednisone—Crohn's disease	3.34e-05	0.0132	CcSEcCtD
Diphenhydramine—Hypotension—Azathioprine—Crohn's disease	3.34e-05	0.0132	CcSEcCtD
Diphenhydramine—Dry mouth—Mesalazine—Crohn's disease	3.32e-05	0.0131	CcSEcCtD
Diphenhydramine—HRH1—Signaling by GPCR—GPR65—Crohn's disease	3.32e-05	0.000865	CbGpPWpGaD
Diphenhydramine—Confusional state—Mesalazine—Crohn's disease	3.28e-05	0.013	CcSEcCtD
Diphenhydramine—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	3.26e-05	0.000851	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MTMR3—Crohn's disease	3.26e-05	0.000851	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.21e-05	0.000837	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ACKR2—Crohn's disease	3.21e-05	0.000836	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.19e-05	0.000833	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.19e-05	0.000833	CbGpPWpGaD
Diphenhydramine—Thrombocytopenia—Mesalazine—Crohn's disease	3.18e-05	0.0126	CcSEcCtD
Diphenhydramine—Tachycardia—Mesalazine—Crohn's disease	3.17e-05	0.0126	CcSEcCtD
Diphenhydramine—PTGS1—Metabolism—MTMR3—Crohn's disease	3.17e-05	0.000826	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	3.16e-05	0.000825	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	3.16e-05	0.000825	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	3.15e-05	0.000823	CbGpPWpGaD
Diphenhydramine—Hyperhidrosis—Mesalazine—Crohn's disease	3.14e-05	0.0125	CcSEcCtD
Diphenhydramine—Anorexia—Mesalazine—Crohn's disease	3.1e-05	0.0123	CcSEcCtD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.07e-05	0.000802	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MTMR3—Crohn's disease	3.04e-05	0.000793	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MLN—Crohn's disease	3.04e-05	0.000793	CbGpPWpGaD
Diphenhydramine—Hypotension—Mesalazine—Crohn's disease	3.04e-05	0.012	CcSEcCtD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	3.02e-05	0.000788	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.99e-05	0.00078	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MLN—Crohn's disease	2.99e-05	0.00078	CbGpPWpGaD
Diphenhydramine—Sweating increased—Prednisone—Crohn's disease	2.95e-05	0.0117	CcSEcCtD
Diphenhydramine—Feeling abnormal—Azathioprine—Crohn's disease	2.94e-05	0.0117	CcSEcCtD
Diphenhydramine—Insomnia—Mesalazine—Crohn's disease	2.94e-05	0.0117	CcSEcCtD
Diphenhydramine—Paraesthesia—Mesalazine—Crohn's disease	2.92e-05	0.0116	CcSEcCtD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.91e-05	0.00076	CbGpPWpGaD
Diphenhydramine—Somnolence—Mesalazine—Crohn's disease	2.89e-05	0.0115	CcSEcCtD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	2.88e-05	0.000752	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.86e-05	0.000747	CbGpPWpGaD
Diphenhydramine—Dyspepsia—Mesalazine—Crohn's disease	2.86e-05	0.0113	CcSEcCtD
Diphenhydramine—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	2.84e-05	0.000741	CbGpPWpGaD
Diphenhydramine—Decreased appetite—Mesalazine—Crohn's disease	2.83e-05	0.0112	CcSEcCtD
Diphenhydramine—Fatigue—Mesalazine—Crohn's disease	2.8e-05	0.0111	CcSEcCtD
Diphenhydramine—Constipation—Mesalazine—Crohn's disease	2.78e-05	0.011	CcSEcCtD
Diphenhydramine—HRH1—Signaling Pathways—TAGAP—Crohn's disease	2.78e-05	0.000725	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	2.74e-05	0.000714	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.73e-05	0.000711	CbGpPWpGaD
Diphenhydramine—Feeling abnormal—Mesalazine—Crohn's disease	2.68e-05	0.0106	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Prednisone—Crohn's disease	2.64e-05	0.0105	CcSEcCtD
Diphenhydramine—HRH1—GPCR downstream signaling—CCR6—Crohn's disease	2.6e-05	0.000679	CbGpPWpGaD
Diphenhydramine—Urticaria—Mesalazine—Crohn's disease	2.58e-05	0.0102	CcSEcCtD
Diphenhydramine—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	2.56e-05	0.000668	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—FADS1—Crohn's disease	2.54e-05	0.000663	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.49e-05	0.000649	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	2.48e-05	0.000647	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—FADS1—Crohn's disease	2.47e-05	0.000644	CbGpPWpGaD
Diphenhydramine—Diarrhoea—Azathioprine—Crohn's disease	2.44e-05	0.00968	CcSEcCtD
Diphenhydramine—HRH1—Signaling Pathways—RSPO3—Crohn's disease	2.43e-05	0.000634	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTMR3—Crohn's disease	2.42e-05	0.00063	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	2.41e-05	0.000629	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	2.39e-05	0.000624	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GPX4—Crohn's disease	2.38e-05	0.000621	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—FADS1—Crohn's disease	2.37e-05	0.000618	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CCR6—Crohn's disease	2.36e-05	0.000616	CbGpPWpGaD
Diphenhydramine—Dizziness—Azathioprine—Crohn's disease	2.36e-05	0.00935	CcSEcCtD
Diphenhydramine—Asthenia—Mesalazine—Crohn's disease	2.33e-05	0.00924	CcSEcCtD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.33e-05	0.000608	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.33e-05	0.000608	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	2.32e-05	0.000606	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GPX4—Crohn's disease	2.31e-05	0.000603	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SEL1L—Crohn's disease	2.3e-05	0.000601	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GCKR—Crohn's disease	2.3e-05	0.0006	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	2.29e-05	0.000597	CbGpPWpGaD
Diphenhydramine—Vomiting—Azathioprine—Crohn's disease	2.27e-05	0.00899	CcSEcCtD
Diphenhydramine—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	2.27e-05	0.000591	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	2.25e-05	0.000588	CbGpPWpGaD
Diphenhydramine—Rash—Azathioprine—Crohn's disease	2.25e-05	0.00892	CcSEcCtD
Diphenhydramine—Dermatitis—Azathioprine—Crohn's disease	2.25e-05	0.00891	CcSEcCtD
Diphenhydramine—Headache—Azathioprine—Crohn's disease	2.24e-05	0.00886	CcSEcCtD
Diphenhydramine—PTGS1—Metabolism—GCKR—Crohn's disease	2.23e-05	0.000582	CbGpPWpGaD
Diphenhydramine—Diarrhoea—Mesalazine—Crohn's disease	2.22e-05	0.00881	CcSEcCtD
Diphenhydramine—SLC22A1—Metabolism—GPX4—Crohn's disease	2.22e-05	0.000579	CbGpPWpGaD
Diphenhydramine—Dizziness—Mesalazine—Crohn's disease	2.15e-05	0.00852	CcSEcCtD
Diphenhydramine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	2.15e-05	0.00056	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GCKR—Crohn's disease	2.14e-05	0.000559	CbGpPWpGaD
Diphenhydramine—Nausea—Azathioprine—Crohn's disease	2.12e-05	0.0084	CcSEcCtD
Diphenhydramine—HRH1—Signaling Pathways—CCR9—Crohn's disease	2.11e-05	0.00055	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	2.08e-05	0.000543	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCR9—Crohn's disease	2.07e-05	0.000541	CbGpPWpGaD
Diphenhydramine—Vomiting—Mesalazine—Crohn's disease	2.07e-05	0.00819	CcSEcCtD
Diphenhydramine—Rash—Mesalazine—Crohn's disease	2.05e-05	0.00812	CcSEcCtD
Diphenhydramine—Dermatitis—Mesalazine—Crohn's disease	2.05e-05	0.00812	CcSEcCtD
Diphenhydramine—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	2.05e-05	0.000534	CbGpPWpGaD
Diphenhydramine—Headache—Mesalazine—Crohn's disease	2.04e-05	0.00807	CcSEcCtD
Diphenhydramine—Vision blurred—Prednisone—Crohn's disease	1.99e-05	0.00787	CcSEcCtD
Diphenhydramine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.98e-05	0.000515	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GPR65—Crohn's disease	1.96e-05	0.000511	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.96e-05	0.000511	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL3—Crohn's disease	1.95e-05	0.000509	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.95e-05	0.000508	CbGpPWpGaD
Diphenhydramine—Agitation—Prednisone—Crohn's disease	1.94e-05	0.00768	CcSEcCtD
Diphenhydramine—Nausea—Mesalazine—Crohn's disease	1.93e-05	0.00765	CcSEcCtD
Diphenhydramine—CHRM2—Signaling Pathways—GPR65—Crohn's disease	1.93e-05	0.000503	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	1.92e-05	0.000501	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.92e-05	0.0005	CbGpPWpGaD
Diphenhydramine—Vertigo—Prednisone—Crohn's disease	1.89e-05	0.0075	CcSEcCtD
Diphenhydramine—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	1.89e-05	0.000492	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—FADS1—Crohn's disease	1.88e-05	0.000491	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.88e-05	0.00049	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	1.86e-05	0.000484	CbGpPWpGaD
Diphenhydramine—Convulsion—Prednisone—Crohn's disease	1.83e-05	0.00724	CcSEcCtD
Diphenhydramine—CYP2C19—Metabolism—MTMR3—Crohn's disease	1.83e-05	0.000476	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL3—Crohn's disease	1.77e-05	0.000462	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GPX4—Crohn's disease	1.76e-05	0.00046	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL3—Crohn's disease	1.74e-05	0.000455	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	1.71e-05	0.000447	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GCKR—Crohn's disease	1.7e-05	0.000444	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	1.69e-05	0.00044	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.68e-05	0.000438	CbGpPWpGaD
Diphenhydramine—Tachycardia—Prednisone—Crohn's disease	1.68e-05	0.00665	CcSEcCtD
Diphenhydramine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.67e-05	0.000436	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.66e-05	0.000434	CbGpPWpGaD
Diphenhydramine—Hyperhidrosis—Prednisone—Crohn's disease	1.66e-05	0.00659	CcSEcCtD
Diphenhydramine—Anorexia—Prednisone—Crohn's disease	1.64e-05	0.0065	CcSEcCtD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.59e-05	0.000416	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.56e-05	0.000407	CbGpPWpGaD
Diphenhydramine—Insomnia—Prednisone—Crohn's disease	1.56e-05	0.00617	CcSEcCtD
Diphenhydramine—Paraesthesia—Prednisone—Crohn's disease	1.54e-05	0.00612	CcSEcCtD
Diphenhydramine—Dyspepsia—Prednisone—Crohn's disease	1.51e-05	0.006	CcSEcCtD
Diphenhydramine—Decreased appetite—Prednisone—Crohn's disease	1.5e-05	0.00593	CcSEcCtD
Diphenhydramine—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	1.48e-05	0.000387	CbGpPWpGaD
Diphenhydramine—Fatigue—Prednisone—Crohn's disease	1.48e-05	0.00588	CcSEcCtD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.48e-05	0.000385	CbGpPWpGaD
Diphenhydramine—Constipation—Prednisone—Crohn's disease	1.47e-05	0.00583	CcSEcCtD
Diphenhydramine—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	1.46e-05	0.000381	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.46e-05	0.00038	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.42e-05	0.000371	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—FADS1—Crohn's disease	1.42e-05	0.000371	CbGpPWpGaD
Diphenhydramine—Feeling abnormal—Prednisone—Crohn's disease	1.42e-05	0.00562	CcSEcCtD
Diphenhydramine—HRH1—Signaling Pathways—CCR6—Crohn's disease	1.4e-05	0.000364	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.4e-05	0.000364	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCR6—Crohn's disease	1.37e-05	0.000358	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	1.37e-05	0.000356	CbGpPWpGaD
Diphenhydramine—Urticaria—Prednisone—Crohn's disease	1.37e-05	0.00542	CcSEcCtD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	1.34e-05	0.000351	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GPX4—Crohn's disease	1.33e-05	0.000347	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—FADS1—Crohn's disease	1.31e-05	0.000341	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—FADS1—Crohn's disease	1.3e-05	0.000338	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GCKR—Crohn's disease	1.29e-05	0.000336	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RBX1—Crohn's disease	1.26e-05	0.000329	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RBX1—Crohn's disease	1.24e-05	0.000324	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	1.24e-05	0.000324	CbGpPWpGaD
Diphenhydramine—Asthenia—Prednisone—Crohn's disease	1.23e-05	0.00489	CcSEcCtD
Diphenhydramine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	1.23e-05	0.00032	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPX4—Crohn's disease	1.23e-05	0.00032	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	1.22e-05	0.000319	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPX4—Crohn's disease	1.21e-05	0.000317	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	1.21e-05	0.000315	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GCKR—Crohn's disease	1.18e-05	0.000309	CbGpPWpGaD
Diphenhydramine—Diarrhoea—Prednisone—Crohn's disease	1.18e-05	0.00466	CcSEcCtD
Diphenhydramine—CYP2C9—Metabolism—GCKR—Crohn's disease	1.17e-05	0.000306	CbGpPWpGaD
Diphenhydramine—Dizziness—Prednisone—Crohn's disease	1.14e-05	0.00451	CcSEcCtD
Diphenhydramine—CYP1A2—Metabolism—FADS1—Crohn's disease	1.11e-05	0.000289	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	1.11e-05	0.000289	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ALB—Crohn's disease	1.1e-05	0.000287	CbGpPWpGaD
Diphenhydramine—Vomiting—Prednisone—Crohn's disease	1.09e-05	0.00433	CcSEcCtD
Diphenhydramine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	1.09e-05	0.000284	CbGpPWpGaD
Diphenhydramine—Rash—Prednisone—Crohn's disease	1.08e-05	0.0043	CcSEcCtD
Diphenhydramine—Dermatitis—Prednisone—Crohn's disease	1.08e-05	0.00429	CcSEcCtD
Diphenhydramine—Headache—Prednisone—Crohn's disease	1.08e-05	0.00427	CcSEcCtD
Diphenhydramine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	1.07e-05	0.00028	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	1.06e-05	0.000275	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL3—Crohn's disease	1.05e-05	0.000273	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPX4—Crohn's disease	1.04e-05	0.000271	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL3—Crohn's disease	1.03e-05	0.000269	CbGpPWpGaD
Diphenhydramine—Nausea—Prednisone—Crohn's disease	1.02e-05	0.00405	CcSEcCtD
Diphenhydramine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	1.01e-05	0.000264	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GCKR—Crohn's disease	1e-05	0.000261	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	9.96e-06	0.00026	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTGS2—Crohn's disease	9.64e-06	0.000251	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.19e-06	0.00024	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	9.18e-06	0.00024	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	9.17e-06	0.000239	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	9.04e-06	0.000236	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	9.02e-06	0.000235	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	8.74e-06	0.000228	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	8.6e-06	0.000224	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	8.38e-06	0.000219	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.38e-06	0.000219	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	8.34e-06	0.000218	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	8.25e-06	0.000215	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	8.21e-06	0.000214	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.04e-06	0.00021	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	7.92e-06	0.000207	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	7.79e-06	0.000203	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	7.61e-06	0.000199	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	7.49e-06	0.000195	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.33e-06	0.000191	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	7.33e-06	0.000191	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—Crohn's disease	7.31e-06	0.000191	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	7.21e-06	0.000188	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.16e-06	0.000187	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—Crohn's disease	7.1e-06	0.000185	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—Crohn's disease	6.82e-06	0.000178	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—Crohn's disease	6.4e-06	0.000167	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.27e-06	0.000163	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—Crohn's disease	6.21e-06	0.000162	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—Crohn's disease	5.96e-06	0.000156	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—Crohn's disease	5.42e-06	0.000141	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TYK2—Crohn's disease	5.16e-06	0.000135	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	5.08e-06	0.000133	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JAK2—Crohn's disease	4.93e-06	0.000129	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	4.85e-06	0.000126	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—Crohn's disease	4.74e-06	0.000124	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	4.5e-06	0.000117	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	4.42e-06	0.000115	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—Crohn's disease	4.28e-06	0.000112	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	4.21e-06	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—Crohn's disease	4.09e-06	0.000107	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—Crohn's disease	3.77e-06	9.82e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—Crohn's disease	3.73e-06	9.74e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—Crohn's disease	3.62e-06	9.43e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—Crohn's disease	3.58e-06	9.34e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	3.56e-06	9.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.29e-06	8.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—Crohn's disease	3.27e-06	8.52e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—Crohn's disease	3.19e-06	8.32e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.79e-06	7.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—Crohn's disease	2.53e-06	6.59e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—Crohn's disease	2.49e-06	6.48e-05	CbGpPWpGaD
